Use of Statistics to Assess the Global Burden of Breast Cancer
暂无分享,去创建一个
[1] NATIONAL CANCER INSTITUTE OF CANADA. , 1949, Canadian Medical Association journal.
[2] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[3] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[4] S D Walter,et al. Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.
[5] L. Tabár,et al. REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.
[6] J. Yarnold,et al. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Joan M. Anderson. Migration and health: perspectives on immigrant women. , 1987 .
[8] M Baum,et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[9] A. Korzun,et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] F. Alexander. Estimation of sojourn time distributions and false negative rates in screening programmes which use two modalities. , 1989, Statistics in medicine.
[11] D. Parkin. Cancers of the breast, endometrium and ovary: geographic correlations. , 1989, European journal of cancer & clinical oncology.
[12] Terry L. Smith,et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? , 1990, Cancer.
[13] H. D. de Koning,et al. Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.
[14] L. Sanderson,et al. Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[15] L. Tabár,et al. Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.
[16] D. Morisky,et al. Mammography Usage and the Health Belief Model , 1992, Health education quarterly.
[17] A M Nomura,et al. Migration patterns and breast cancer risk in Asian-American women. , 1993, Journal of the National Cancer Institute.
[18] Jacques Estève,et al. Trends in cancer incidence and mortality. , 2009 .
[19] S. Hopper,et al. The influence of ethnicity on the health of older women. , 1993, Clinics in geriatric medicine.
[20] D. Parkin,et al. Cancer in Italian Migrant Populations , 1993 .
[21] M. Gerretsen,et al. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.
[22] T. Landberg,et al. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. , 1993, Acta oncologica.
[23] M Baum,et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Coebergh,et al. Is the peak in breast cancer incidence in sight? A study conducted in the southeastern Netherlands. , 1994, European journal of cancer.
[25] P. Rheinstein,et al. The Mammography Quality Standards Act of 1992. , 1994, American family physician.
[26] P. Boffetta,et al. Cancer in developing countries , 1994, CA: a cancer journal for clinicians.
[27] Mike Clarke,et al. EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .
[28] K Smigel,et al. Breast cancer death rates decline for white women. , 1995, Journal of the National Cancer Institute.
[29] A. Tamakoshi,et al. Epidemiology of breast cancer in Japan. , 1995, International journal of epidemiology.
[30] C. Sargent,et al. Gender and Health: An International Perspective , 1995 .
[31] Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).
[32] M Quinn,et al. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening , 1995, BMJ.
[33] Latino male attitudes and behaviors on their spouses' and partners' cancer-screening behavior: focus group findings. , 1995, Journal of the National Cancer Institute. Monographs.
[34] W. Chie,et al. Age-period-cohort analysis of breast cancer mortality. , 1995, Anticancer research.
[35] F. Houn,et al. The Mammography Quality Standards Act of 1992. History and philosophy. , 1995, Radiologic clinics of North America.
[36] B A Miller,et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. , 1996, Journal of the National Cancer Institute.
[37] J. Bonneterre,et al. A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine. , 1996, PharmacoEconomics.
[38] J. Kelsey,et al. Epidemiology and prevention of breast cancer. , 1996, Annual review of public health.
[39] R. Roetzheim,et al. The effects of health beliefs on screening mammography utilization among a diverse sample of older women. , 1997, Women & health.
[40] V. Champion,et al. Recent mammography in women aged 35 and older: predisposing variables. , 1996, Health care for women international.
[41] R. Peto. Five years of tamoxifen--or more? , 1996, Journal of the National Cancer Institute.
[42] S. Duffy,et al. Breast cancer in Singapore: trends in incidence 1968-1992. , 1996, International journal of epidemiology.
[43] B. Borman,et al. Breast cancer in New Zealand: trends, patterns, and data quality. , 1996, The New Zealand medical journal.
[44] A. Recht,et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. , 1996, The New England journal of medicine.
[45] M. A. Trapp,et al. A program to increase breast and cervical cancer screening for Cambodian women in a midwestern community. , 1996, Mayo Clinic proceedings.
[46] P Selby,et al. Benefits from specialised cancer care , 1996, The Lancet.
[47] A. Garber,et al. Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.
[48] Eero Pukkala,et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.
[49] J. Benichou,et al. Ethnicity and variation in breast cancer incidence , 1997 .
[50] W. Holzemer,et al. Helpseeking for self-discovered breast symptoms. Implications for early detection. , 1997, Cancer practice.
[51] A. Avgar. Women's health in Israel: a feminist perspective. , 1997, Social work in health care.
[52] D. Stockton,et al. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment? , 1997, BMJ.
[53] A. Gregor,et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] Richard A. Krueger,et al. Analyzing and Reporting Focus Group Results , 1997 .
[55] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[56] R. Sankaranarayanan. Cancer Survival in Developing Countries , 1998 .
[57] H. Adami,et al. Recent trends in breast cancer incidence in Sweden , 1998 .
[58] N. Day,et al. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis , 1998, Journal of medical screening.
[59] Mireille J. M. Broeders,et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .
[60] C. Murray,et al. Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[61] K I Bland,et al. The National Cancer Data Base 10‐year survey of breast carcinoma treatment at hospitals in the United States , 1998, Cancer.
[62] D. Parkin,et al. An overview of cancer survival in developing countries. , 1998, IARC scientific publications.
[63] J. Walley,et al. Assessing health needs in developing countries , 1998, BMJ.
[64] A. Kricker,et al. Breast cancer mortality trends in Australia: 1921 to 1994 , 1998, The Medical journal of Australia.
[65] S. Shapiro,et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. , 1998, International journal of epidemiology.
[66] A. Kricker,et al. Breast cancer in New South Wales in 1972–1995: Tumor size and the impact of mammographic screening , 1999, International journal of cancer.
[67] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[68] E. Rutten,et al. Erratum to “ The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study” [Radiother. Oncol. 52 (1999) 101–109]☆ , 1999 .
[69] S. Underwood,et al. Veiled yet vulnerable. Breast cancer screening and the Muslim way of life. , 1999, Cancer practice.
[70] J. Norum,et al. Breast cancer screening by mammography in Norway. Is it cost-effective? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[71] L. Remennick. Breast screening practices among Russian immigrant women in Israel. , 1999, Women & health.
[72] M. Somerfield,et al. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] A. Meghzifene,et al. Radiation therapy in Africa: distribution and equipment. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[74] S. Devesa,et al. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. , 1999, Journal of the National Cancer Institute.
[75] Richard Sylvester,et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.
[76] D. Parkin,et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997 , 2000, British Journal of Cancer.
[77] Mike Clarke,et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years , 2000, The Lancet.
[78] R. Blanks,et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.
[79] Omar M. Salazar,et al. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). , 2000 .
[80] K McPherson,et al. Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.
[81] L Collette,et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[82] L. Tabár,et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.
[83] D B Evans,et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] H. Adami,et al. Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.
[85] S. Redman,et al. Evaluating the effectiveness of advocacy training for breast cancer advocates in Australia. , 2001, European journal of cancer care.
[86] J. V. van Engelshoven,et al. Diagnostic value of radiological breast imaging in a non‐screening population , 2001, International journal of cancer.
[87] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[88] H. Tatsuzaki,et al. Quantitative status of resources for radiation therapy in Asia and Pacific region. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[89] L. Remennick. All my life is one big nursing home , 2001 .
[90] D. Peterson,et al. Needs Assessment in Public Health: A Practical Guide for Students and Professionals , 2001 .
[91] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[92] Roberta M Ray,et al. Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.
[93] T. Whelan,et al. Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer , 2002 .
[94] Alan D. Lopez,et al. Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site , 2002, BMC Cancer.
[95] Paola Pisani,et al. Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.
[96] H. Tatsuzaki,et al. Radiotherapy services in countries in transition: gross national income per capita as a significant factor. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[97] B. E. F. Isher,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .
[98] Efficacy, toxicity, and cost-effectiveness of single-dose versus fractionated hemibody irradiation (HBI). , 2002, International journal of radiation oncology, biology, physics.
[99] Alan D. Lopez,et al. Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000 , 2002, BMC Cancer.
[100] Radiotherapy in the management of early breast cancer in Ibadan: outcome of chest wall irradiation alone in clinically nodes free axilla. , 2002, African journal of medicine and medical sciences.
[101] Umberto Veronesi,et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.
[102] A. Hedley,et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis , 2002, British Journal of Cancer.
[103] A. Bener,et al. The determinants of breast cancer screening behavior: a focus group study of women in the United Arab Emirates. , 2002, Oncology nursing forum.
[104] L. Brinton,et al. Recent trends in breast cancer incidence and mortality , 2002, Environmental and molecular mutagenesis.
[105] Rob Baltussen,et al. Programme costs in the economic evaluation of health interventions , 2003, Cost effectiveness and resource allocation : C/E.
[106] F Berrino,et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[107] D Hölzel,et al. The process of metastasisation for breast cancer. , 2003, European journal of cancer.
[108] Stephen Taplin,et al. Early Detection of Breast Cancer in Countries with Limited Resources , 2003, The breast journal.
[109] D. Radice,et al. Breast cancer management: quality-of-life and cost considerations. , 2003, PharmacoEconomics.
[110] Anthony Rodgers,et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.
[111] D. Parkin,et al. Cancer in Africa : epidemiology and prevention , 2003 .
[112] Christopher J L Murray,et al. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.
[113] C. Holt,et al. Development of a spiritually based breast cancer educational booklet for African American women. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[114] L. Tabár,et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.
[115] Roman Shyyan,et al. Introduction of Breast Cancer Screening in Chernihiv Oblast in the Ukraine: Report of a PATH Breast Cancer Assistance Program Experience , 2003, The breast journal.
[116] B. Green,et al. The perspective of African‐American breast cancer survivor‐advocates , 2003, Cancer.
[117] S. Braun. The History of Breast Cancer Advocacy , 2003, The breast journal.
[118] Lisa Barbera,et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[119] D. Parkin,et al. Time trends in cancer mortality in China: 1987–1999 , 2003, International journal of cancer.
[120] A. Miller,et al. Why is breast-cancer mortality declining? , 2003, The Lancet. Oncology.
[121] G. Giles,et al. Evaluation of the organised mammographic screening programme in Australia. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[122] Taghreed Adam,et al. Cost Effectiveness and Resource Allocation Econometric Estimation of Country-specific Hospital Costs , 2003 .
[123] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.
[124] Rob Baltussen,et al. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .
[125] B. Stewart,et al. World Cancer Report , 2003 .
[126] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[127] L. Tabár,et al. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. , 2003, European journal of cancer.
[128] B. Yeole,et al. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[129] G. Dziekan,et al. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings. , 2003, Bulletin of the World Health Organization.
[130] F. Bray,et al. Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.
[131] C. Nagata,et al. Trends in the incidence rate and risk factors for breast cancer in Japan , 1997, Breast Cancer Research and Treatment.
[132] L. Remennick. “I Have No Time for Potential Troubles”: Russian Immigrant Women and Breast Cancer Screening in Israel , 2003, Journal of Immigrant Health.
[133] Rob Baltussen,et al. Accounting for the cost of scaling-up health interventions. , 2004, Health economics.
[134] T. Holford. Trends in cancer incidence and mortality , 1995, Cancer Causes & Control.
[135] Barbara L. Smith,et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.
[136] H. Bartelink,et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial , 2004 .
[137] E. Feuer,et al. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? , 1995, Cancer Causes & Control.
[138] K. Hess,et al. Surgical treatment of metastatic brain tumors , 1996, Journal of Neuro-Oncology.
[139] R. Baltussen,et al. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. , 2004, Bulletin of the World Health Organization.
[140] Breast cancer advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition. , 2004, European journal of cancer.
[141] Carmen DeNavas-Walt,et al. Income, Poverty, and Health Insurance Coverage in the United States: 2004 , 2006 .
[142] E. Borrayo,et al. Are All Latinas the Same? Perceived Breast Cancer Screening Barriers and Facilitative Conditions , 2004 .
[143] David Rajasekar,et al. Improvement of radiotherapy facilities in developing countries: a three-tier system with a teleradiotherapy network. , 2004, The Lancet. Oncology.
[144] A. Taghian,et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[145] F. Bray,et al. The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.
[146] H. Bartelink,et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[147] G. Hortobagyi,et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[148] E. Eng,et al. Natural helping functions of lay health advisors in breast cancer education , 2004, Breast Cancer Research and Treatment.
[149] D. Zaridze,et al. Incidence of cancer of the lung stomach, breast, and cervix in the USSR: pattern and trends , 1990, Cancer Causes & Control.
[150] A. Walker,et al. Breast cancer in black African women: a changing situation , 2004, The journal of the Royal Society for the Promotion of Health.
[151] R. Jagsi,et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. , 2003, International journal of radiation oncology, biology, physics.
[152] Iris Pigeot,et al. Handbook of epidemiology , 2005 .
[153] J. Bellon,et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[154] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[155] John J Spinelli,et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. , 2005, Journal of the National Cancer Institute.
[156] N. Beşe,et al. The Effect of Treatment Interruptions in the Postoperative Irradiation of Breast Cancer , 2005, Oncology.
[157] B. Vikram,et al. Breast Cancer in Limited‐Resource Countries: Treatment and Allocation of Resources , 2006, The breast journal.
[158] I. Nyirjesy. Enthusiasm for Cancer Screening in the United States , 2008 .